Tandem duplications in triple negative breast cancer

Increasing diversity through the NCI SBIR development centre

The importance of online patient groups and 'The ROS1ders'

Effects of dasatinib on xenograft lung tumour models with YES1 overexpression

Analysis tools for NCI genomic databases

Results from GOBACK: Non-chromosomal birth defects linked with cancer

A link between non-chromosomal birth defects and cancer

Novel gene biomarkers in multiple cancers derived from non-malignant breast phenotypes

Reducing recurrence of advanced melanoma with pembrolizumab

Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.

Clinical development and economic prospects of CAR T cell immunotherapies

Theranostic imaging of lymphoma using radiolabelled αCD19-antibodies